Tumour Genetic Testing

Solid Tumour Molecular Profiling

GenomixLAB’s Solid Tumour Molecular Profiling is offered using curated biomarker content in across 161 cancer-related genes based on the latest therapy developments, medical guidelines, and clinical trials. The simultaneous analysis of both DNA and RNA facilitates the detection of mutations, Copy Number Variants, and known and novel fusions. Gene fusions are an increasingly important target in precision oncology.

Two Panels are available;

Comprehensive Cancer Panel

Focus Tumour Panel

Liquid Biopsy Testing Panels